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Abstract
Background: CD147 is a broadly distributed integral membrane glycoprotein with two Ig-like
domains implicated in a wide range of functions. It is associated at the cell surface with the
monocarboxylate transporters MCT1 and 4 but interactions of the extracellular region have not
been characterised.
Results: We report the characterisation of a form of CD147 with an additional membrane-distal
Ig-like domain. In contrast to the two domain form, this three domain form of CD147 interacts
homophilically. Surface plasmon resonance analysis using recombinant proteins showed that the
interaction was of low affinity (KD ~ 40 µM) and this is typical of many interactions between
membrane proteins. cDNA for the 3 domain form are rare but have been identified in human and
mouse retina.
Conclusion: The finding that the three domain form of CD147 has an extracellular ligand, that is
it interacts homophilically, suggests this interaction may be important in aligning lactate
transporters in the retina where lactate is an important metabolite.
Background
CD147 is a widely expressed membrane glycoprotein
(also called OX47, basigin, EMMPRIN and HT7) and has
been implicated in matrix metalloproteinase induction,
cell adhesion, retinal cell development, HIV attachment,
embryonic development, and T cell activation [1–5]. The
transmembrane region has a very high degree of cross spe-
cies homology, being identical between chicken and rat
and containing a centrally positioned glutamic acid. This
is crucial for its lateral association with monocarboxylate
transport molecules MCT1 and MCT4 [6]. MCT1 and
MCT4 are proton-coupled transporters of monocarboxy-
lates, principally the metabolic intermediate lactate [7]. It
may be that some of the diverse functions attributed to
CD147 are due to effects on the carboxylate transporters.
The extracellular region of CD147 contains 2 Ig-like
domains. This is very common in leukocyte membrane
proteins and these proteins often interact with other cell
surface proteins [8]. No extracellular ligand has yet been
identified for CD147 although an interaction with cyclo-
philin has been shown to be mediated by glycosaminogly-
cans [2]. Despite extensive studies using a variety of
constructs for recombinant proteins we have not found
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any cellular ligands (unpublished data) and it may be that
the role of CD147 is through cis interactions in the organ-
isation of MCTs at the cell surface.
CD147 belongs to a family that contains the synaptic glyc-
oprotein SDR1 (ZOV3, synaptic glycoprotein gp55/65 or
np55/65, neuroplastin) [9] and GP70 (or embigin)
[10,11]. The three proteins are well conserved (37–46%
amino acid sequence identity) with no other proteins
showing comparable similarity to the group. Like CD147,
GP70 associates laterally with MCT1 [12]; whether SDR1
participates in a similar interaction has yet to be deter-
mined. SDR1 is expressed in two isoforms produced by
alternative splicing, np55 (a two domain form with wide-
spread expression) and np65 (a three domain form, asso-
ciated with post synaptic membranes) [13,14]. Np55
shows considerable sequence similarity with CD147 (Fig.
1) and GP70 but the additional domain of np65 shows
little similarity with the either protein. However, there is a
region within the first intron of the murine CD147 gene
that, if translated, would generate a polypeptide with 3 Ig-
like domains and with a high degree of similarity to np65.
Very recently this three domain form has been shown to
give rise to protein that is expressed in some cells in the
retina [15]. As the three domain form np65 has been
shown to interact homophilically, this raises the possibil-
ity that CD147 exists in a form suitable for homophilic
interactions [14].
Here we express CD147 recombinant protein containing
this third Ig-like domain (d0) and demonstrate that this
form interacts homophilically with a KD of approximately
40 µM and an T1/2 of 1 second. This homophilic interac-
tion may affect the subcellular distribution of the CD147-
MCT complex, positioning monocarboxylate transporters
at sites of cell-cell contact for optimal intercellular trans-
port of lactate.
Amino acid sequence alignment of mouse, human and chicken CD147 and neuroplastin Figure 1
Amino acid sequence alignment of mouse, human and chicken CD147 and neuroplastin. The sequence of mouse 
and human domain 0 is in bold. The approximate predicted positions of the beta strands in the Ig-like domains, the transmem-
brane (TM) and the cytoplasmic regions are indicated. The glutamic acid residue in the transmembrane region is marked with 
an asterisk. Sequences are from GenBank; CD147 human; AF548371, mouse CD147; AY089967; Chicken X52751 and neuro-
plastin 65 (Np65); NM_012428.
Signal
Chicken CD147 M A A G A D V P C A V L A L L V L G S L A A -----------------------------------------------
Mouse CD147 M A A A L L L A L A F T L L S G Q G A C A A --------AGFLKAPLSQERW AGGSVVLHCEAVGSPIPEIQWW FEGN
Human CD147 M A A A L F V L L G F A L L G T H G A S G A --------AGFVQAPLSQQRW VGGSVELHCEAVGSPVPEIQWW FEGQ
Np65 M S G S S L P S A L A L S L L L V S G S L L P G P G A A Q N A G F VKSPMSETKLTGDAFELYCDVVGSPTPEIQ W WYAEV
Chicken CD147 ----------------------------------------------------------------------
Mouse CD147 APNDSCSQLW DGARLDRVH I HAAYRQHAASSLSVDGLTAEDTGTYECRASSDPDRNHLTRPPRVKW VRAQ
Human CD147 GPNDTCSQLW DGARLDRVH I HATYHQHAAST I S I DTLVEEDTGTYECRASNDPDRNHLTRAPRVKW VRAQ
Np65 N R A E S F R Q L W D G A R K R R V T V N T A Y G S N G V S V L R I T R L T L E D S G T Y E C R A S N D P K R N D L R Q N P S I T W I R A Q
Chicken CD147 - - G G D A T G P V I T G Q Y S S -----S A D K V V L S C NISAPPTL IKGHKW MLGDKVLKTDESDASSYISYT IEGK
Mouse CD147 ASVVVLEPGT IQ T S V Q E-----V N S K T Q L T C S L N S S G V DIV G H R W M R G G K V L Q E D T L P D---L H T K YIV D
Human CD147 AVVLVLEPGTV F T T V E D-----L G S KIL L T C S L N D S A T E V T G H R W L K G G V V L K E D A L P G --- Q K T E F K V D
Np65 A T I S V L Q K P R I V T SEEVI IRDSPVLPVTLQCNLTSSSHTLTYSYWTKNGVELSATRKNAS-NMEYRINKP
Chicken CD147 V E D H S G V Y E C I Y N T N PVAKGNVSIEVE- -PQVVAYKKSEHGNEGDVGVLTCKSPS-YPPVDHWAWYKSGQ
Mouse CD147 A D D R S G E Y S C I F L PEPVGRSEINVEGP- -PRIKVGKKSEHSSEGELAKLVCKSDASYPPI TDWFWFKTSD
Human CD147 S D D Q W G E Y S C V F L P E P M G T A N I Q L H G P - - P R VKAVKSSEHINEGETAMLVCKSES-VPPVTDWAWYKI TD
Np65 R A E D S G E Y H C V Y H F VSAPKANAT IEVKAAPDI TGHKRSENKNEGQDATMYCKSVGYPHPDWIWRKKEN
Chicken CD147 T -----V P L ESSAG- IYNISRTGNKTELRI LKLNIEQDMGDYSCNGTNMKGSGSATVNLRVRSR
Mouse CD147 T G EEEAI TNSTEANGKYVVVSTPEKSQLT ISNLDVNVDPGTYVCNATNAQGTTRET ISLRVRSR
Human CD147 S - E D K A L M N G S E S - - R F F VSSSQGRSELHIENLNMEADPGQYRCNGTSSKGSDQAI I TLRVRSH
Np65 G ---- M P M DIV N T S G R F FIIN K E N Y T E L NIV N L QIT E D P G E Y E C N A T N AIG SASVVTVLRVRSH
Chicken CD147 L A A L W P F L G I VAEVLVLVT I I F IYEKRRKPDEVLDDDDGGSAPLKSNAT - -NHKDKNVRQRNAT
Mouse CD147 M A A L W P F L G I VAEVLVLVT I I F IYEKRRKPDQTLDEDDPGAAPLKGSGTHMNDKDKNVRQRNAT
Human CD147 L A A L W P F L G I VAEVLVLVT I I F IYEKRRKPEDVLDDDDAGSAPLKSSGQHQNDKGKNVRQRNSS
Np65 L A P L W P F L G I L A E I I I L V V I I VVYEKRKRPDEVPDDDEPAG-PMKTNSTN NHKDKNLRQRNTN
*
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Results
Identification of a putative third Ig-like domain of CD147 
in human and mouse genomes
A comparison of the putative extra exon in the mouse
CD147 gene against the genomic sequence of human
CD147 using pairwise BLAST [16] revealed a correspond-
ing region. If these regions were to be transcribed, the
resulting polypeptide would be 80% identical between
human and mouse. A homologous mRNA is also
expressed in Xenopus (EST AW158254), with 61% pre-
dicted amino-acid identity to the mouse homologue. This
demonstrates a significantly higher degree of evolutionary
conservation than for the two previously recognised Ig-
like domains of CD147 (56% and 46% identity human-
mouse). The predicted polypeptide translated from exon
1b is clearly identifiable as an Ig-like domain; it has the
two conserved cysteine residues that generally form an
intra-domain disulphide bond, and motifs characteristic
of a C2-set Ig-like domain (Fig. 1). An unusual feature
shared by the predicted domain in mouse and human is
an additional cysteine residue in the predicted C' strand
region. No other unpaired cysteine residue is found in the
extracellular region of CD147. The high level of evolu-
tionary conservation of exon 1b makes it highly likely that
this exon gives rise to protein, implying that CD147 exists
in two or more alternatively spliced isoforms. In both
mouse and human genes, exon 1b has a typical in-frame
splice site complying with the 'GT-AG rule'. In common
with most exons encoding IgSF domains, the exon bound-
ary is in phase 1, occurring after the first base of a codon
(codon 2 of the mature protein).
Recently Ochrietor et al. [15] have shown that this three
domain form is present in mouse, rat, human, chicken
and zebrafish retina pointing to the importance of this
isoform. To conform to conventional numbering of IgSF
domains in CD147, the additional N-terminal domain
encoded by exon 1b will be referred to as domain 0 (d0).
Cloning of the novel domain of mouse CD147 and 
production of soluble recombinant CD147 extracellular 
regions
With no known source of cDNA containing the CD147
exon 1b, genomic DNA was used as the template. Primers
were designed complementary to the 5' and 3' ends of
exon 1b (see Methods) to establish PCR conditions. Once
a product was obtained, primers for the shorter
mCD147d0 product were used on the genomic DNA to
obtain third domain sequence (Fig. 1, bold). A soluble
recombinant protein was generated that had mCD147d0
fused to the extracellular region of rat CD147
(rCD147d1+2), in turn fused to domains 3 and 4 of rat
CD4 (rCD4d3+4) with an additional biotinylation
sequence at the COOH terminus for biotinylation using
the BirA enzyme (mCD147d0rCD147d1+2rCD4d3+4). A
schematic representation is shown in Figure 2A (III). In
addition, mCD147d0 was fused to
mCD147d1+2rCD4d3+4 (Fig. 2A (IV)). Purified proteins
are shown in Figure 2B. Two bands were always seen with
the proteins containing rCD147d1+2 (Fig. 2B lanes II and
III) and may be due to variable glycosylation.
Production of mAbs against three domain mouse CD147
Rats were initially immunized with purified soluble
recombinant md0-2rCD4d3+4 (Fig. 2A (IV)) and spleen
cells were fused to Y3 myeloma cells. Hybridomas were
obtained reacting with recombinant protein by ELISA.
mAb OX114 was able to detect both the three domain
Recombinant CD147 proteins Figure 2
Recombinant CD147 proteins. A. Schematic representa-
tion of constructs used in the study. Bold lines indicate rat 
CD4 domains 3+4, thin lines represent mouse CD147 
domains, and dotted lines represent rat CD147 domains 
1+2. B. SDS PAGE of purified recombinant proteins. Lane I: 
rCD4d3+4, lane II: rCD147d1+2rCD4d3+4, lane III: 
mCD147d0rCD147d1+2rCD4d3+4, lane IV: mCD147d0-
2rCD4d3+4.
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(Fig. 3A, thick grey line) and the two domain forms (Fig.
3A, thin black line) of mCD147 on the surface of trans-
fected HEK293T cells. When these cells were solubilized,
subjected to SDS-PAGE and western blotted, as shown in
Fig 3B, no band was visualized in the untransfected lane
(U), whereas a single band of 38 kDa was seen in the two
domain lane, and a single band of 50 kDa was seen in the
three domain lane. The specificity of OX114 mAb for
domain 1 or 2 was confirmed biochemically. The recom-
binant proteins shown in Figure 2 were immobilized onto
a BIAcore™ chip by capture with OX68, an anti-CD4 mAb
and tested for OX114 mAb reactivity. Binding was only
found in the flow cell containing mCD147d0-2 (Fig. 3C,
the solid line), indicating that it was specific for domains
1 or 2 of mCD147. OX114 mAb gave good staining of
mouse thymocytes and to sections of fixed tissue showing
the mAb recognized native CD147 (data not shown). It is
difficult to raise mAbs recognising mouse CD147 and this
seems to be the first published. Several attempts to raise
mAb specific for d0 by immunization with combinations
of md0-2rCD4d3+4, md0rd1-2rCD4d3+4 and rat cells
transfected with CD147 (3d form) were unsuccessful.
OX114 mAb binds both two and three domain forms of mouse CD147 Figure 3
OX114 mAb binds both two and three domain forms of mouse CD147. A. Flow cytometry of OX114 mAb binding 
transfected 293T cells. Light grey line represents untransfected cells, black line represents cells expressing mouse CD147d1+2, 
dark grey line represents cells expressing mouse CD147d0-2. B. Western blot of transfected 293T lysates. Lane U, untrans-
fected cells, 2d, cells transfected with mouse CD147 d1+2, 3d, cells transfected with mouse CD147d0-2. Each lane contains 
lysate from 106 cells. C. Ability of OX114 mAb to bind to recombinant protein on the Biacore™. Proteins as illustrated in Fig-
ure 2 were immobilized on the chip, and OX114 mAb was passed over as indicated. OX114 mAb only binds to constructs con-
taining mouse CD147d1+2.
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The three domain form of CD147 binds homophilically – 
determination of affinity
As the three domain form of neuroplastin np65 but not
the two domain form, had been shown to interact
homophilically [14] we tested to see if the three domain
form of CD147 interacted homophilically by surface plas-
mon resonance using a BIAcore. Recombinant bioti-
nylated mCD147d0-2rCD4d3+4 was immobilized on the
sensor surface via streptavidin. This bound mAb OX114
strongly and assuming bivalent binding of the antibody,
indicated that at least 80% of the immobilized
mCD147d0-2rCD4d3+4 was antigenically active and
likely to be correctly folded (data not shown). To ensure
the unbiotinylated mCD147d0-2rCD4d3+4 was mono-
meric prior to affinity measurements, the affinity purified
protein was subjected to gel filtration immediately prior
to affinity analysis to prevent aggregation (time elapsed
between gel filtration and affinity measurement was no
more than 2 h). Changes in response were observed when
105 µM mCD147d0-2rCD4d3+4 was passed over immo-
bilized mCD147d0-2rCD4d3+4, but not over a control
protein, hCD5d1-3rCD4d3+4 at 25°C (data not shown).
The three domain form of CD147 interacts homophilically Figure 4
The three domain form of CD147 interacts homophilically. A. BIAcore trace showing soluble rCD147d1-2rCDd3+4 
at 45 µM passed over control biotinylated rCD147d1-2rCDd3+4 (1854 RU) and rCD4d1-4 (5946 RU) at 25 °C. The period of 
injection is indicated by the bar above the trace. There is no difference between the two flow cells showing no specific binding 
and the signal is due to the high concentration of protein passing over the chip. B. BIAcore trace showing four different con-
centrations (µM) of soluble mCD147d0-2rCDd3+4 passed over (and indicated by the bars over the trace) control biotinylated 
hCD5d1-3rCD4d3+4 (2033 RU) and biotinylated mCD147d0-2rCDd3+4 (1069 RU) at 37°C. C. The specific binding data in 
(B) i.e. after subtraction of signal over control flow cell were analysed using a non-linear curve fit graph to equation 7 [17] 
assuming KD1 = KD2. D. Non-linear curve fit to off rate data for soluble mCD147d0-2rCD4d3+4 dissociating at 37°C from 
mCD147d0-2rCD4d3+4 immobilized at 1455 RU.
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This binding was detectable down to concentrations of 2
µM. To ensure this interaction was mediated by the third
domain, rCD147d1+2rCD4d3+4 was tested for its ability
to self associate in a similar manner at 25°C. There was no
detectable binding when 45 µM rCD147d1+2rCD4d3+4
was passed over directly immobilized
rCD147d1+2rCD4d3+4 (Fig 4A). The immobilized pro-
tein was shown to be active by antibody binding (OX47
and PE-2, data not shown).
The affinity of the homophilic mCD147d0-2rCD4d3+4
interaction was calculated at 37°C by injecting a series of
different concentrations of purified soluble mCD147d0-
2rCD4d3+4 over immobilized mCD147d0-2rCD4d3+4
and a negative control of hCD5d1-3rCD4d3+4 (Fig. 4B).
The binding is represented by the increase in response
units (RU) observed relative to that in the control flow cell
(Fig. 4B) once equilibrium has been reached and is plot-
ted as a binding curve (Fig. 4C). The weak binding is typ-
ical of that of many cell surface protein interactions. The
KD cannot simply be calculated from these data because
the situation is complicated by the ability of the material
to interact homophilically in solution and on the chip in
addition to the binding from solution to chip. Previous
analysis on the CD150 homophilic interaction had estab-
lished methods to do this taking the fluid phase and
immobilized interactions into account [17]. Assuming all
interactions were of the same affinity, the data gave a best
fit for an affinity of KD = 36 µM (Fig. 4C). The resultant
concentration of immobilized CD147 Af is slightly higher
than that calculated (121 µM) using equation 14 [17] and
an experimentally determined value for P of 5.8. This may
be due to uneven coating of the chip with CD147 and the
discrepancy is reduced at higher levels of immobilized
CD147. At a calculated concentration of immobilized
CD147 of 138 µM, two affinity determinations gave KD =
39  µM and KD = 35 µM with Af = 150 and 151 µM
respectively.
Kinetic analysis of the interaction at 37°C yielded a Koff =
0.7 s-1  (Fig. 4D) for all levels of immobilization of
mCD147d0-2, indicating that kinetic measurements were
not affected by rebinding. Kon values were calculated by
fitting the association binding phase to a simple 1:1
binding model using a Koff of 0.7 s-1 and were about 7 ×
104 M-1 s-1 (Fig. 4). The t1/2 is 1 s.
Discussion
Here we report the characterisation of an isoform of
mCD147 containing a membrane distal third Ig-like
domain. Unlike the two domain form, the three domain
form can interact homophilically with a relatively low
affinity of KD = 40 µM. This affinity is typical of many pro-
tein interactions between cell surface proteins that are
often in the range 1–100 µM [18]. Several other proteins
with IgSF domains have been shown to interact
homophilically including SLAM (CD150), NCAM,
PECAM (CD31) and the coxsackievirus and adenovirus
receptor (CAR). Using the same methods as here the affin-
ity of the 2 IgSF domain protein CD150 had a KD of
around 200 µM [17] indicating a somewhat weaker inter-
action than CD147. CD150 is involved in control of T cell
activation and has activation motifs in its cytoplasmic
region. Data for other interactions are less easy to compare
as different methods and temperatures have been used.
For example the KD for homophilic interactions of pro-
teins with IgSF domains are NCAM, 100 µM [19,20], CAR
16 µM [21], CD31 12.5 µM [22]. The desmosomal cad-
herins have a higher affinity with a KD of 4.2 µM [23].
NCAM is involved in neuronal development; CAR is best
defined as a virus receptor but also for homophilic inter-
actions where interestingly it has been implicated in the
control of small molecules across tight junctions [24].
CD31 is involved in interactions between endothelial
cells, has inhibitory motifs in the cytoplasmic regions but
has additional ligands [25].
We have been unable to determine the distribution of the
three-domain form of CD147 due to difficulty in raising
specific high affinity mAb for d0. We were successful in
producing the first mAb against mouse CD147 that was
effective in staining cells in suspension and in tissue sec-
tions. Previously polyclonal antiserum has been used to
identify mouse CD147. The three domain form is clearly
rare as CD147 has been biochemically characterised in
detail from many tissues but only in retina has a high-
molecular weight form been detected [26]. Recently
cDNAs for the three domain form have been identified.
Of 13 known ESTs encoding human CD147 d0, 9 were
derived from retina, indicating a tightly restricted expres-
sion. During preparation of this paper, Ochrietor et al.
showed the three-domain form of CD147 was expressed
in tissue lysate from retina, but not from other tissues
including brain, lung, liver and spleen and specifically
labelled the photoreceptor cells [15]. We have previously
shown that the two Ig-domain form of CD147 associates
laterally with the monocarboxylate transport proteins
MCT1 and MCT4 and is vital for the transport of the trans-
porters to the cell surface [6]. This requirement for co-
expression is manifested in vivo by the greatly diminished
expression of MCT1, 3 and 4 in the retina of CD147-null
mice [27], which provides a likely explanation for the ret-
inal degeneration observed in these mice [15].
Immunoprecipitation studies have shown that CD147
can form oligomers [28,29]. These cis interactions
between CD147 depended on the NH2 terminal domain
of CD147 [29]. Fluorescence resonance energy transfer
experiments have confirmed the close association
between CD147 and MCT1 and shown the minimumBMC Biochemistry 2003, 4 http://www.biomedcentral.com/1471-2091/4/17
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complex formation contains two CD147 proteins and two
MCT1s [30]. We were unable to detect any direct binding
using the two domain CD147 form and indeed using
highly avid multivalent recombinant forms of
mCD147d1+2, we have been unable to demonstrate cell
surface ligands (unpublished data). It is possible that the
cis interactions involving the NH2 terminal domain of
CD147 observed by Yoshida et al. [29] require close prox-
imity at the cell surface as they were not detectable in
trans. Our assays are more comparable to the trans situa-
tion and may not detect very weak cis interactions.
Homophilic interactions of cell-surface proteins typically
result in their accumulation at sites of cell-cell contact. A
likely consequence of the homophilic interaction of three-
domain CD147 is therefore to cause accumulation of
CD147, and consequently of MCTs, at sites of cell-cell
contact. There is a comparable interaction with the
sodium channel. In this case, the alpha chain that medi-
ates transport is associated with a single pass beta chain
that contains a single Ig-like domain that can interact
homophilically and bring ankyrin associated with the
cytoplasmic region to the point of cell-cell contact [31].
This organisation of MCTs at closely positioned opposing
cell membranes would create an efficient interface for
intercellular transport of monocarboxylates and there is
evidence of close proximity of transporters on opposing
membranes in retina [32]. Such an effect would be
uniquely desirable in the retina, as Muller cells and pho-
toreceptors are metabolically coupled, with the highly gly-
colytic Muller cells producing an excess of lactate, which
is taken up by photoreceptors and used as a substrate for
oxidative metabolism [33,34]. (Both Muller and photore-
ceptor cells express the three domain form with higher
levels in the photoreceptors) [15]. In tissues where the
homophilic interaction is not required, the two domain
form of CD147 is sufficient to facilitate surface expression
of MCT. Whether two domain CD147 has additional
activities is unclear.
Conclusions
We have identified the first ligand for the extracellular
region of CD147 in finding that the rare three domain
form interacts homophilically. As cDNA for this form is
largely restricted to retina, it suggests that CD147 (three
domain form) is important in aligning MCT in the retinal
and hence directing lactate transport.
Methods
DNA constructs
The cDNA for mouse CD147 was obtained from Teruo
Miyauchi (Japan Immunoresearch Laboratories Co., Ltd).
All primers were obtained from Sigma-Genosys (Cam-
bridge, UK). The for constructs with CD4 domains were as
in [35,36]. Primers for mCD147 are shown below with
the coding sequence in lower case and restrictions sites
underlined and sense primers are given first. mCD147d0
CATCTAGATTGTCGACagctggtttcctcaaggcaccactgtc,
CTGGCCACTCGAGtcaaggaccaccacgctcgcctgggcacg
mCD147; exon 1b CCGCTAGCtggtttcctcaaggcaccactgtc,
TGGCCACGTAGACtcaaggacgaccacgctcgcctgggcacg;
mCD147L-cytoplasmic tail 
TAGTAGTCTAGAatggcggcgctg,
TAGGGATCCtcaggtggcgttcct
Generation of transfected cell lines
Soluble recombinant CD147 proteins were expressed
using the pEE14 vector [36] in Chinese hamster ovary
(CHO)-K1 cells. The CD147 extracellular regions (mouse
CD147 domains 0 to 2; mCD147d0-2, mouse CD147
domains 1 and 2; mCD147d1+2, mouse CD147 domain
0 on rat CD147 domains 1 and 2;
mCD147d0rCD147d1+2) were cloned into a pEFBOS
vector between the rat CD4 leader sequence and rat CD4
domains 3+4 (rCD4d3+4) followed by a biotinylation
sequence tag [35]. A schematic representation of the
resultant recombinant proteins is shown in Figure 2.
Transfection was carried out using Fugene (Roche Molec-
ular Biochemicals, Welwyn Garden City, UK) as per man-
ufacturer's instructions. Constructs for cell surface CD147
were expressed in pEFBOS in human embryonic kidney
(HEK) 293-T cells [37]. The full length mouse CD147d0-
2 with transmembrane and cytoplasmic tail (mCD147d0-
cyt) was expressed with the rat CD4 leader and mouse
CD147 d1-cytoplasmic tail (mCD147d1-cyt) was with the
mouse CD147 leader. Transfection was carried out using
Fugene as described above, and cells were harvested 3
days after transfection.
Purification of protein
The recombinant proteins were purified from spent tissue
culture supernatant with an anti rat CD4 (OX68 mAb)
affinity column [38,39]. Concentration was calculated
using a calculated molar extinction coefficient of 80880
cm-1 M-1.
Biotinylation of protein
Purified protein was dialyzed into 10 mM Tris-HCl, pH 8,
and concentrated to 0.5–0.8 ml using a 10,000 MW cut off
Centricon (Amicon, Inc., Beverly, MA) and incubated
with 1 µl BirA enzyme (Avidity, Denver, CO). Biotinyla-
tion was complete after 2–4 hours at 30°C or overnight at
room temperature as assessed by binding of chimeras to
streptavidin immobilized via OX68 (a CD4d3+4 mAb) on
the BIAcore™.
Monoclonal antibodies recognising CD147
mAb were produced by standard methods using the Y3 rat
myeloma fusion partner. The immunisation schedule that
was successful for OX114 consisted of three injections ofBMC Biochemistry 2003, 4 http://www.biomedcentral.com/1471-2091/4/17
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20 µg recombinant mCD147d0-2rCD4d3+4. mAb were
screened by ELISA on recombinant proteins and cells.
Antibody isotype was determined using Rat Ig Isotyping
Kit (Pharmingen). Combinations of these proteins and
mCD147d0rCD147d102rCD4d3+4 were used in unsuc-
cessful attempts to obtain a CD147d0 specific mAb.
Protein interaction determined by surface plasmon 
resonance in the BIAcore™
Affinity analysis was performed on a BIAcore 2000™
(BIAcore AB, St. Albans, UK). Streptavidin (0.2 mg/ml in
10 mM sodium acetate, pH 5, Pierce Chemical Co. Rock-
ford, IL) was coupled to a research grade CM5 BIAcore™
chip using an amine coupling kit supplied by the manu-
facturer. After an activation time of 5 min, between 2000–
3000 response units (RU) of streptavidin were immobi-
lized. The surface of the chip was washed with 0.1 M gly-
cine-HCl, pH 2.5 after coupling. Recombinant
biotinylated mCD147d0-2rCD4d3+4 at a concentration
of 40 µg/ml, or biotinylated hCD5d1-3rCD4d3+4 (con-
trol) from tissue culture supernatant were injected over
immobilized streptavidin. The running buffer was HBS
buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 3.4 mM
EDTA, and 0.005% surfactant P20). Equilibrium affinity
measurements were carried out at 37°C as [17]. Briefly,
increasing and decreasing concentrations of mCD147d0-
2rCD4d3+4 (5 µl injections at 20 µl/min) were passed
over mCD147d0-2rCD4d3+4 and human CD5 domains
1 to 3 (hCD5d1-3rCD4d3+4). Origin software, version
5.0 (Medical Software, Inc., Northampton, MA) was used
in the analysis taking into account possible association in
liquid phase and on the chip as discussed in [17].
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